Try a new search

Format these results:

Searched for:

school:SOM

Department/Unit:Neurology

Total Results:

22948


Global & Community Health: Neurologic care for Latinos in South Philadelphia: Global health at home

O'Kula, Susanna S; Aamodt, Whitley W; Rubenstein, Michael N
PMID: 31477612
ISSN: 1526-632x
CID: 4366442

A dual role of prestimulus spontaneous neural activity in visual object recognition

Podvalny, Ella; Flounders, Matthew W; King, Leana E; Holroyd, Tom; He, Biyu J
Vision relies on both specific knowledge of visual attributes, such as object categories, and general brain states, such as those reflecting arousal. We hypothesized that these phenomena independently influence recognition of forthcoming stimuli through distinct processes reflected in spontaneous neural activity. Here, we recorded magnetoencephalographic (MEG) activity in participants (N = 24) who viewed images of objects presented at recognition threshold. Using multivariate analysis applied to sensor-level activity patterns recorded before stimulus presentation, we identified two neural processes influencing subsequent subjective recognition: a general process, which disregards stimulus category and correlates with pupil size, and a specific process, which facilitates category-specific recognition. The two processes are doubly-dissociable: the general process correlates with changes in criterion but not in sensitivity, whereas the specific process correlates with changes in sensitivity but not in criterion. Our findings reveal distinct mechanisms of how spontaneous neural activity influences perception and provide a framework to integrate previous findings.
PMCID:6718405
PMID: 31477706
ISSN: 2041-1723
CID: 4068992

CASE STUDIES IN NEUROSCIENCE: INSTABILITY OF THE VISUAL NEAR TRIAD IN TRAUMATIC BRAIN INJURY - EVIDENCE FOR A PUTATIVE CONVERGENCE INTEGRATOR

Rucker, Janet C; Buettner-Ennever, Jean; Straumann, Dominik; Cohen, Bernard
Deficits of convergence and accommodation are common following traumatic brain injury, including mild traumatic brain injury, though the mechanism and localization of these deficits have been unclear and supranuclear control of the near-vision response has been incompletely understood. We describe a patient who developed profound instability of the near-vision response with inability to maintain convergence and accommodation following mild traumatic brain injury, who was identified to have a structural lesion on brain MRI in the pulvinar of the caudal thalamus, the pretectum, and the rostral superior colliculus (SC). We discuss the potential relationship between post-traumatic clinical near-vision response deficits and the MRI lesion in this patient. We further propose that the MRI lesion location, specifically the rostral superior colliculus, participates in neural integration for convergence holding, given its proven anatomic connections with the central mesencephalic reticular formation (cMRF) and C-group medial rectus motoneurons in the oculomotor nucleus which project to extraocular muscle non-twitch fibers specialized for fatigue-resistant, slow, tonic activity such as vergence holding.
PMID: 31339793
ISSN: 1522-1598
CID: 3987242

Dynamic functional connectivity changes associated with dementia in Parkinson's disease

Fiorenzato, Eleonora; Strafella, Antonio P; Kim, Jinhee; Schifano, Roberta; Weis, Luca; Antonini, Angelo; Biundo, Roberta
Dynamic functional connectivity captures temporal variations of functional connectivity during MRI acquisition and it may be a suitable method to detect cognitive changes in Parkinson's disease. In this study, we evaluated 118 patients with Parkinson's disease matched for age, sex and education with 35 healthy control subjects. Patients with Parkinson's disease were classified with normal cognition (n = 52), mild cognitive impairment (n = 46), and dementia (n = 20) based on an extensive neuropsychological evaluation. Resting state functional MRI and a sliding-window approach were used to study the dynamic functional connectivity. Dynamic analysis suggested two distinct connectivity 'States' across the entire group: a more frequent, segregated brain state characterized by the predominance of within-network connections, State I, and a less frequent, integrated state with strongly connected functional internetwork components, State II. In Parkinson's disease, State I occurred 13.89% more often than in healthy control subjects, paralleled by a proportional reduction of State II. Parkinson's disease subgroups analyses showed the segregated state occurred more frequently in Parkinson's disease dementia than in mild cognitive impairment and normal cognition groups. Further, patients with Parkinson's disease dementia dwelled significantly longer in the segregated State I, and showed a significant lower number of transitions to the strongly interconnected State II compared to the other subgroups. Our study indicates that dementia in Parkinson's disease is characterized by altered temporal properties in dynamic connectivity. In addition, our results show that increased dwell time in the segregated state and reduced number of transitions between states are associated with presence of dementia in Parkinson's disease. Further studies on dynamic functional connectivity changes could help to better understand the progressive dysfunction of networks between Parkinson's disease cognitive states.
PMCID:6736370
PMID: 31280293
ISSN: 1460-2156
CID: 4090822

LATE to the PART-y

Josephs, Keith A; Mackenzie, Ian; Frosch, Matthew P; Bigio, Eileen H; Neumann, Manuela; Arai, Tetsuaki; Dugger, Brittany N; Ghetti, Bernardino; Grossman, Murray; Hasegawa, Masato; Herrup, Karl; Holton, Janice; Jellinger, Kurt; Lashley, Tammaryn; McAleese, Kirsty E; Parisi, Joseph E; Revesz, Tamas; Saito, Yuko; Vonsattel, Jean Paul; Whitwell, Jennifer L; Wisniewski, Thomas; Hu, William
PMID: 31359030
ISSN: 1460-2156
CID: 4283942

Long-term Cognitive Consequences for Patients With Pediatric-Onset Multiple Sclerosis

Krupp, Lauren B; Charvet, Leigh E
PMID: 31206137
ISSN: 2168-6157
CID: 3938902

Response by Jordan et al to Letter Regarding Article, "Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source" [Comment]

Jordan, Kevin; Yaghi, Shadi; Song, Christopher
PMID: 31409271
ISSN: 1524-4628
CID: 4339442

Comparison of intranasal midazolam versus intravenous lorazepam for seizure termination and prevention of seizure clusters in the adult epilepsy monitoring unit

Owusu, Kent A; Dhakar, Monica B; Bautista, Cynthia; McKimmy, Dani; Cotugno, Stephanie; Sukumar, Nitin; Deng, Yanhong; Farooque, Pue; Hirsch, Lawrence J; Maciel, Carolina B
OBJECTIVE:The objective of the study was to compare the performance of intravenous (IV) lorazepam (IVL) and intranasal midazolam (INM) for seizure termination and prevention of seizure clusters in adults admitted to the epilepsy monitoring unit (EMU) in whom seizures were captured on continuous video-electroencephalogram. METHODS:Retrospective cohort of consecutive adults (≥18 years) with epilepsy admitted to the EMU at a single tertiary academic center, who experienced epileptic seizures (confirmed electroencephalographically) and required rescue therapy. The study spanned from January 2015 until December 2016, which included one year before and one year after transitioning from IVL to INM as the standard rescue therapy at our institution. RESULTS:A total of 50 subjects received rescue therapy and were included in the analysis. In the first year, out of 216 patients with epilepsy admitted to the EMU, 27 (13%) received IVL; in the second year, 23/217 (11%) received INM. There were no differences in baseline characteristics and markers of epilepsy severity, the median duration of index seizure (1.7 min [interquartile range (IQR): 1.1-2.7] in IVL vs. 2.0 min [IQR: 1.5-2.6] in INM group, p = 0.20), or in the number of subjects requiring repeat benzodiazepine administrations (IVL 8/27 [29.6%] vs. INM 7/23 [30.4%], p = 0.95). There were no differences in the median number of recurrent seizures in 24 h (1 [IQR: 1-3] in IVL vs. 2 [IQR: 1-4] in INM, p = 0.27), occurrence of status epilepticus (IVL 4/27 [14.8%] subjects vs. INM 1/23 [4.3%] subjects, p = 0.36), incidence of seizure clusters (IVL 8/27 [29.6%] subjects vs. INM 7/23 [30.4%] subjects, p = 0.95), need for transfer to an intensive care unit (ICU), or other adverse events. SIGNIFICANCE:In our retrospective study, INM was comparable with IVL for seizure termination and prevention of seizure clusters in the adult EMU. Intranasal midazolam circumvents the need for IV access to be maintained throughout hospitalization and is an attractive alternative to IVL as a rescue therapy in this setting. Ideally, future large, prospective, randomized, and double blind studies are needed to confirm these findings.
PMID: 31374472
ISSN: 1525-5069
CID: 5401752

Efficacy of fremanezumab in migraine patients with medication overuse and documented inadequate response to 2-4 migraine preventive medications: Subgroup analysis of the randomised, placebo-controlled focus study [Meeting Abstract]

Silberstein, S; Cohen, J M; Ramirez-Campos, V; Yang, R; Galic, M; Ning, X; Jann, A
Objective: The FOCUS study of fremanezumab, a fullyhumanised monoclonal antibody (IgG2DELTAa) that selectively targets calcitonin gene-related peptide (CGRP), was the first and largest study of a migraine preventive treatment in adults with both chronic and episodic migraine (CM and EM) and documented inadequate response to 2-4 classes of migraine preventive medications. Efficacy in a subgroup of patients with medication overuse (use of any acute medication on >=15 days/month or triptans/ergots/combination medications on >=10 days/month) at baseline (BL) was evaluated.
Method(s): Patients were randomised (1:1:1) to quarterly (qtly) fremanezumab (Month [Mo] 1: 675 mg; Mo 2 and 3: placebo), monthly (mthly) fremanezumab (Mo 1: CM, 675 mg; EM, 225 mg; Mo 2 and 3: 225 mg), or matched mthly placebo for 12 weeks. Changes from BL in mthly migraine days and headache days of at least moderate severity at 4 weeks and during 12 weeks of treatment were compared using a mixed-effect model for repeated measures.
Result(s): Of 838 randomised patients, 427 had medication overuse. Reductions from BL in mthly average migraine days and headache days of at least moderate severity at 4 weeks and during 12 weeks of treatment were significantly greater with both fremanezumab regimens vs placebo (all P<=0.0001; Table).
Conclusion(s): Qtly and mthly fremanezumab provided early and sustained reductions in migraine and headache days vs placebo in patients with medication overuse and documented inadequate response to 2-4 classes of migraine preventive medications. (Table Presented)
EMBASE:629410741
ISSN: 1468-2982
CID: 4119922

Correction to: Continuous subcutaneous apomorphine infusion in Parkinson's disease: causes of discontinuation and subsequent treatment strategies

Olivola, Enrica; Fasano, Alfonso; Varanese, Sara; Lena, Francesco; Santilli, Marco; Femiano, Cinzia; Centonze, Diego; Modugno, Nicola
The published version of this article unfortunately contained a mistake in Table 2. CGI-S and CGI-I values has been interchanged. The Table is corrected here.
PMID: 31257551
ISSN: 1590-3478
CID: 4090232